Noble Biomaterials Revenue and Competitors

Scranton, PA USA

Location

$8M

Total Funding

Estimated Revenue & Valuation

  • Noble Biomaterials's estimated annual revenue is currently $17.1M per year.(i)
  • Noble Biomaterials's estimated revenue per employee is $140,000
  • Noble Biomaterials's total funding is $8M.

Employee Data

  • Noble Biomaterials has 122 Employees.(i)
  • Noble Biomaterials grew their employee count by -2% last year.

Noble Biomaterials's People

NameTitleEmail/Phone
1
Chief Process EngineerReveal Email/Phone
2
CEOReveal Email/Phone
3
EVP ManufacturingReveal Email/Phone
4
VP, Technical OperationsReveal Email/Phone
5
VP - Technical Services & IntegrationReveal Email/Phone
6
VP, Eastern RegionReveal Email/Phone
7
EVP OperationsReveal Email/Phone
8
VP Healthcare DivReveal Email/Phone
9
SVP SalesReveal Email/Phone
10
Technical Director, Conductive ProductsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6955.7M2027910%N/AN/A
Add Company

What Is Noble Biomaterials?

The story of Noble Biomaterials, Inc. begins at a turn-of-the-century textile mill in New York named Sauquoit. Originally a cotton spinning mill, the company eventually moved operations to Scranton, PA in 1873. There, Sauquoit functioned as a silk spinning facility and experienced rapid growth to become one of the country’s largest silk weavers. Operations continued for an entire century until the early 1900’s when the advent of man-made fibers, rayon and acetate brought a new market direction. Sauquoit adapted quickly to become a leader in processing filament yarns. The company was an early entrant into the textured yarn business going on to produce a new fiber called “Nylon®” under license of DuPont® industries. A key turning point came in 1997, as the company was sold and Noble Fiber Technologies was founded. During that time conductive fiber technology utilizing silver was created for use in industrial markets. This novel manufacturing process led to the invention of a new technology that would eventually be branded X-STATIC®. This innovative new technology was immediately explored for applications in anti-static carpeting, and in doing so, Noble Fiber Technologies began its next evolution “from silk to technology.”

keywords:Biotechnology

$8M

Total Funding

122

Number of Employees

$17.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Noble Biomaterials News

2022-04-17 - Anti-Static Fibres Market Size, Outlook And Forecast | Akrilic ...

... Swicofil, WL Gore & Associates, Cytec Industries Inc, Tianyu Textile, Yantai Tayho Advanced Materials, Noble Biomaterials.

2022-04-06 - Crystal Denim first to use Noble Biomaterials' silver-ion tech ...

Crystal Denim, the denim division of Crystal International, has launched a new line of denim featuring Noble Biomaterials' Ionic+ technology...

2022-04-06 - The global biomaterials market is estimated to register a CAGR of 12.78% during the forecast period, 2022-2030

Evonik Industries, BASF, Royal DSM, Covestro AG, Zimmer Biomet Holdings Inc, Mitsubishi Chemical Holdings Corporation, Noble Biomaterials...

2013-10-17 - Noble Biomaterials reups with KCI

Noble Biomaterials, a bacterial management company, said it renewed its partnership with KCI Manufacturing, an affiliate of Kinetic Concepts Inc., for its V.A.C. GranuFoam silver dressing. The new agreement allows for Noble to continue as KCI Manufacturing’s antimicrobial technology partner for ...

2012-02-10 - Noble Biomaterials Raises $8M in Series B Equity Financing

Noble Biomaterials, Inc., a Scranton, PA-based provider of bacterial management solutions, has raised $8m in Series B equity financing. The round was led by Northwater Capital’s Intellectual Property Fund with participation from existing investors TL Ventures and DuPont Capital Management. The ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.5M1246%N/A
#2
$23.9M1336%N/A
#3
$36.1M1603%N/A
#4
$15M1794%N/A
#5
$46.9M237N/AN/A